15th International Congress on Systemic Lupus Erythematosus and the 43rd Korean College of Rheumatology Annual Scientific Meeting & 17th International Symposium (LUPUS & KCR 2023)(1ÀÏÂ÷) : 2023-05-17
±³À°ÀÏÀÚ : 2023-05-17
±³À°Àå¼Ò : ÄÚ¿¢½º
±³À°ÁÖÁ¦ : 15th International Congress on Systemic Lupus Erythematosus and the 43rd Korean College of Rheumatology Annual Scientific Meeting & 17th International Symposium (LUPUS & KCR 2023)(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
´ã´çÀÚ : ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ
¿¬¶ôó : 02-794-2630
À̸ÞÀÏ : webmaster@rheum.or.kr
±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°ú, Á¤Çü¿Ü°ú, ¿µ»óÀÇÇаú, Áø´Ü°Ë»çÀÇÇаú, °¡Á¤ÀÇÇаú
Âü¼®¿¹»óÀÎ : 1600¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 300,000¿ø
ºñ°í »çÀüµî·Ï: Àü¹®ÀÇ, ¹Ú»ç±Þ ¿¬±¸¿ø, ÀüÀÓÀÇ 300,000¿ø / Àü°øÀÇ, °£È£»ç, ¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø 160,000¿ø ÇöÀåµî·Ï: Àü¹®ÀÇ, ¹Ú»ç±Þ ¿¬±¸¿ø, ÀüÀÓÀÇ 360,000¿ø / Àü°øÀÇ, °£È£»ç, ¼®»ç±Þ ÀÌÇÏ ¿¬±¸¿ø 200,000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 101 13:30~13:50 15-year outcome of Chinese patients with systemic lupus erythematosus: Data from Chinese Systemic Lupus Erythematosus Treatment and Research group Xinping Tian(Peking Union Medical College)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 101 13:50~14:10 Treatment of neuropsychiatric systemic lupus erythematosus: Clinical challenges and future perspectives Pingting Yang(China Medical Univ.)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 101 14:10~14:30 The treatment strategy of systemic lupus erythematosus associated pulmonary arterial hypertension: Evolving into the future Jiuliang Zhao(Peking Union Medical College)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 102 13:30~13:50 Hydroxychloroquine issue Nathalie Costedoat-Chalumeau(Cochin Hosp.)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 102 13:50~14:10 Pregnancy Evelyne Vinet(McGill Univ. Health Centre)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 102 14:10~14:30 Neuropsychiatric systemic lupus erythematosus Alexandra Legge(Dalhousie Univ.)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 105 13:30~13:50 Establishment of the AsiaPacific Lupus Collaboration - Challenges and opportunities Rangi Kandane-rathnayake(Monash Univ.)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 105 13:50~14:10 Scientific outcomes from the AsiaPacific Lupus Collaboration - from endpoint validation to survival factors Eric Morand(Monash Univ.)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 105 14:10~14:30 Treat to target studies in systemic lupus erythematosus - using real world data to strengthen study design Mandana Nikpour(The Univ. of Melbourne)
±³À°½Ã°£ 05¿ù 17ÀÏ ÄÁÆÛ·±½º·ë 205A+B 15:00~15:30 Treat-to-target Ronald Van Vollenhoven(Amsterdam UMC)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 104 15:00~15:12 Introduction and bacterial infection Chi-Chiu Mok(Tuen Mun Hosp.)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 104 15:12~15:24 Tuberculosis and non-tuberculosis mycobacterium infection Laniyati Hamijoyo(Univ. of Padjadjaran)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 104 15:24~15:36 Pneumocystis pneumonitis Koshiro Sonomoto(Univ. of Occupational and Environmental Health)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 104 15:36~15:48 Viral infections (except for Covid-19) Kenji Oku(Kitasato Univ.)
±³À°½Ã°£ 05¿ù 17ÀÏ ±×·£µåº¼·ë 104 15:48~16:00 Covid-19 Lai Shan Tam(The Chinese Univ. of Hong Kong)
±³À°½Ã°£ 05¿ù 17ÀÏ ÄÁÆÛ·±½º·ë 209A+B 15:00~15:30 Disease activity and damage index Matthias Schneider(Heinrich-Heine-Universität Düsseldorf)
±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:00~17:05 Welcome address ¹è»óö(ÇѾç´ëÇб³)
±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:05~17:10 Congratulatory address À̽ż®(Àü³²´ëÇб³)
±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:10~17:20 Overview of LUPUS & KCR 2023 ¹è»óö(ÇѾç´ëÇб³)
±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:20~17:25 Congratulatory address ¿À¼¼ÈÆ(¼¿ïƯº°½ÃÀå)
±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:25~17:30 Teaser of the FoUr ½É½Âö(Ãæ³²´ëÇб³)
±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:30~17:40 The Light ¾çÁö¿ì(Çѱ¹¿¹¼úÁ¾ÇÕÇб³)
±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 17:40~18:00 The Words David McCann(Harvard Univ.)
±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 18:00~18:20 The Height À¯ÇöÁØ(À¯ÇöÁØ °ÇÃà»ç¹«¼Ò)
±âŸ 05¿ù 17ÀÏ ¿ÀµðÅ丮¿ò 18:20~18:30 The Barrier ³ë¼öÇö(°¡¼ö)